Evidence map›Paper›PMID 39791360›Full record

ArticleeLife2025

Oversized cells activate global proteasome-mediated protein degradation to maintain cell size homeostasis.

Shixuan Liu, Ceryl Tan, Chloe Melo-Gavin, Miriam B Ginzberg, Ron Blutrich, Nish Patel, Michael Rape, Kevin G Mark, Ran Kafri

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. miRNA modules for precise, tunable control of gene expression.bioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Scaling of biosynthesis and metabolism with cell size.Molecular biology of the cell · 2022
    Article
  9. What programs the size of animal cells?Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shixuan LiuDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.ORCID https://orcid.org/0000-0003-4972-415X
Ceryl TanDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.ORCID https://orcid.org/0000-0002-9010-9039
Chloe Melo-GavinDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.
Miriam B GinzbergCell Biology, The Hospital for Sick Children, Toronto, Toronto, Canada.
Ron BlutrichDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.
Nish PatelCell Biology, The Hospital for Sick Children, Toronto, Toronto, Canada.
Michael RapeDepartment of Molecular Cell Biology, University of California at Berkeley, Berkeley, United States.ORCID https://orcid.org/0000-0003-4849-6343
Kevin G MarkDepartment of Molecular Cell Biology, University of California at Berkeley, Berkeley, United States.
Ran KafriDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.ORCID https://orcid.org/0000-0002-9656-0189

Funding

Role of Ubiquitination in Neurocristopathies and Neural Crest-Derived CancersF32GM120956 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARK, KEVIN · 2016 to 2018
$174k
Hospital for Sick Children Restracomp Graduate FellowshipHospital for Sick Children Restracomp Postdoc FellowshipNatural Sciences and Engineering Research Council of Canada RGPIN-2015-05805NIGMS NIH HHS F32 GM120956NIGMS NIH HHS F32GM120956University of Toronto Open Fellowship
6 · The paper itself

Abstract

Proliferating animal cells maintain a stable size distribution over generations despite fluctuations in cell growth and division size. Previously, we showed that cell size control involves both cell size checkpoints, which delay cell cycle progression in small cells, and size-dependent regulation of mass accumulation rates (Ginzberg et al., 2018). While we previously identified the p38 MAPK pathway as a key regulator of the mammalian cell size checkpoint (Liu et al., 2018), the mechanism of size-dependent growth rate regulation has remained elusive. Here, we quantified global rates of protein synthesis and degradation in cells of varying sizes, both under unperturbed conditions and in response to perturbations that trigger size-dependent compensatory growth slowdown. We found that protein synthesis rates scale proportionally with cell size across cell cycle stages and experimental conditions. In contrast, oversized cells that undergo compensatory growth slowdown exhibit a superlinear increase in proteasome-mediated protein degradation, with accelerated protein turnover per unit mass, suggesting activation of the proteasomal degradation pathway. Both nascent and long-lived proteins contribute to the elevated protein degradation during compensatory growth slowdown, with long-lived proteins playing a crucial role at the G1/S transition. Notably, large G1/S cells exhibit particularly high efficiency in protein degradation, surpassing that of similarly sized or larger cells in S and G2, coinciding with the timing of the most stringent size control in animal cells. These results collectively suggest that oversized cells reduce their growth efficiency by activating global proteasome-mediated protein degradation to promote cell size homeostasis.

Indexed as

Cell SizeHomeostasisProteasome Endopeptidase ComplexProteolysisAnimalsCell CycleCell ProliferationHumansMiceProtein BiosynthesisProteasome Endopeptidase Complexcell biologycell sizecell size homeostasisgrowth rate compensationhumanproteasome-mediated protein degradation

Identifiers

PMID39791360
PMCPMC11810107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.